Risk factors for potential drug-drug interactions in patients with myasthenia gravis.
Aleksić DZ, Milosavljević MN, Stefanović SM, Bukonjić A, Milosavljević JZ, Janković SM, Božović I, Perić S, Lavrnić D.
Aleksić DZ, et al. Among authors: milosavljevic mn, milosavljevic jz.
Neurol Res. 2021 Dec;43(12):1023-1030. doi: 10.1080/01616412.2021.1948767. Epub 2021 Jul 7.
Neurol Res. 2021.
PMID: 34233604